Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception - Wikidata - wikimedia - TriplyDB

Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception

Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception

http://www.wikidata.org/entity/Q33830084

about

Global report on preterm birth and stillbirth (3 of 7): evidence for effectiveness of interventions.Evaluation of Medication-mediated Effects in Pharmacoepidemiology.Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol Use of antiretrovirals during pregnancy and breastfeeding in low-income and middle-income countries.Birth weight for gestational age norms for a large cohort of infants born to HIV-negative women in Botswana compared with norms for U.S.-born black infants.Predictors of adverse pregnancy outcomes in women infected with HIV in Latin America and the Caribbean: a cohort study.Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction HIV-Associated Tuberculosis in the Newborn and Young Infant.Increased risk of severe infant anemia after exposure to maternal HAART, Botswana.Preterm birth and fetal growth restriction in HIV-infected Brazilian pregnant women.Risk factors for pre-term birth in a Canadian cohort of HIV-positive women: role of ritonavir boosting?Antiretroviral Therapy Use During Pregnancy and the Risk of Small for Gestational Age Birth in a Medicaid Population.The prevalence of stunting is high in HIV-1-exposed uninfected infants in Kenya.Insufficient antiretroviral therapy in pregnancy: missed opportunities for prevention of mother-to-child transmission of HIV in Europe.Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda.In Utero Exposure to Antiretroviral Drugs: Effect on Birth Weight and Growth Among HIV-exposed Uninfected Children in Brazil Combination antiretroviral use and preterm birth.Laboratory Abnormalities Among HIV-Exposed, Uninfected Infants: IMPAACT Protocol P1025 Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trial Antiretroviral use during pregnancy for treatment or prophylaxis.HIV protease inhibitors in pregnancy : pharmacology and clinical use.Antiretroviral therapy and preterm birth in HIV-infected women.British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review).Pregnancy Outcomes in HIV-Infected Women: Experience from a Tertiary Care Center in India Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.PMTCT Option B+ Does Not Increase Preterm Birth Risk and May Prevent Extreme Prematurity: A Retrospective Cohort Study in Malawi.Risk factors for very preterm delivery and delivery of very-small-for-gestational-age infants among HIV-exposed and HIV-unexposed infants in Botswana.Antiretroviral Therapy in Relation to Birth Outcomes among HIV-infected Women: A Cohort Study.Risk of intrauterine growth restriction among HIV-infected pregnant women: a cohort study.Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.Comparison of pregnancy characteristics and outcomes between HIV-infected and HIV-non-infected women in Brazil.Antiretrovirals in pregnancy: a note of caution.Increased risks of preterm birth and a low-birth-weight baby in Thai human immunodeficiency virus-positive pregnant women with periodontitis.Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV.Timing of Initiation of Antiretroviral Therapy and Risk of Preterm Birth in Studies of HIV-infected Pregnant Women: The Role of Selection Bias.Antiretroviral therapy use during pregnancy and adverse birth outcomes in South African women.Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational age.British HIV Association guidelines for the management of HIV infection in pregnant women 2012

P2860

Q30227236-B2C5D2A9-D3DE-4483-88F4-FAF2F0124615 Q33557870-60689073-95AA-4130-940A-5A6904AF47F1 Q33916922-9B7E4F2E-6DFC-4F7D-B29C-D3EDB5AF372D Q34081586-D75ACBFD-FD8E-4008-B701-20B40D6D6983 Q34104017-CD521CCC-2278-46A5-9188-0E6F768733D6 Q34146634-B61724BF-9C23-4194-9405-388C9F56F343 Q34306176-515F7F22-86B1-484C-ADEB-AB7A822A10F6 Q34687799-D7462443-9819-462C-A674-37FDDF8694FF Q34877096-301EE81B-E4A8-4F9D-8AA7-D2E3004F8ACD Q35037981-38A7D8ED-59FB-4858-AA57-C35E79AB6AE8 Q35617411-9A0AA8A3-8A93-42F5-AC63-85FF61421D01 Q35691443-ECA5A46D-C129-4847-94CD-A5C711471E2D Q35738687-942446D7-5731-4310-B611-01D79018810C Q35825248-CE44E623-069C-4E7F-B215-2F2273D081E1 Q36193260-85072D50-8504-47C4-B5BA-BB9A4673B2A4 Q36300046-22AC1AF0-C2BB-482A-A2F5-B2B792FB5F7B Q36443769-8CFB7D98-23D5-4AF2-BB40-AAA4D53E85E0 Q36547343-ADDF94EA-6237-4DD5-B842-88E5A92D96E3 Q36851168-546531FC-31E7-44B8-8309-C874FFA3F630 Q37498149-899CC7E5-BF72-47B4-A122-F7802B2F563A Q37870932-636F7BBB-D36A-4557-986E-CE092CBF2CCD Q38081072-9B4EA66F-1407-46A4-B8E3-85A15AFFA87E Q38185748-D83E6418-3503-4AE7-9075-8C81E5ED77D2 Q38325427-8E736CB9-C811-4E5B-BB68-DF1DC1CA35D6 Q38629430-96D1FC2A-D733-41AA-AE71-C91CAD3E1F9C Q38636802-57E9F11B-E81E-40D6-B816-070324BC3CE9 Q40440550-FA2C5221-20C7-42F3-914B-D589BD7C3C2A Q40797275-6C5E00E9-496F-434E-A50E-3FF649F94D75 Q41057198-F864736D-94F1-4874-B389-B4F30376383A Q42200981-1666F87F-AFB4-4F1B-A199-CD277685E98B Q42248173-8BD021DF-03F6-4670-85B4-0A685FDE0E4C Q42275732-478105FF-7E6D-4A8D-8D8C-6D88AAB49D88 Q42333841-C4D8CA8A-F4F4-4E71-8192-6CCDC38164D9 Q45021366-DBAF5D5E-2FE8-471C-959F-E56531EDD170 Q47162116-B726C6C7-E924-4C45-B49B-F2CEBB03FEAD Q47768538-90F8BB2F-CE8A-4767-8BF7-8A18DC9300AD Q47776480-E9347D6F-BA4F-4745-AC60-DE3DD66C289D Q48206030-B9494E2D-96AC-470A-B4F1-F44B7D63F3C0 Q57076282-86EFBE56-4958-40BA-8B57-E101AA0828F8

P2860

Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception

http://www.wikidata.org/entity/Q33830084

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Pregnancy outcome in women inf ...... before versus after conception

@ast

Pregnancy outcome in women inf ...... before versus after conception

@en

type

label

Pregnancy outcome in women inf ...... before versus after conception

@ast

Pregnancy outcome in women inf ...... before versus after conception

@en

prefLabel

Pregnancy outcome in women inf ...... before versus after conception

@ast

Pregnancy outcome in women inf ...... before versus after conception

@en

P1433

Q33830084-191CE1FC-0548-40AD-A9D2-F661673008D8

P1476

Q33830084-3AC77124-ABF0-4CEE-9C20-955DF881D71F

P2093

Q33830084-3485E059-966C-43A6-9A7D-12D4530F4009

Q33830084-366DBC3A-1C62-43D3-8EA2-5407912F3B41

Q33830084-3D21E8D0-7200-4FD5-B0CA-0628166C8048

Q33830084-666CEEB6-8802-4A5B-92B8-260F5159A6DF

Q33830084-6D1D2524-3444-4E35-AAA8-2E9D5E4E5994

Q33830084-A5DA30AB-F537-43C5-978C-AF7268A7C42E

Q33830084-A66AB9C9-6F38-426F-91EA-6D1A377210E1

Q33830084-B6ABBCDE-CD24-4CDE-BDEA-1FC01A8BBA99

Q33830084-C676B98D-FF63-4C05-8E5E-36CDDFB9C12E

Q33830084-EFE4B7F6-6A52-4038-957C-B45962E8F22D

P2860

Q33830084-0C389490-7627-430D-8689-4BF496EF9E29

Q33830084-16EFD541-F693-4CAD-8266-50E77F19EE18

Q33830084-17333F30-D284-4BB0-B857-2E397BC2FE16

Q33830084-21D8DBDA-0922-49D7-BCE6-A77478106D61

Q33830084-3CF70571-9B74-4F6F-82E2-C5B8756C5916

Q33830084-6C9165D9-CF49-4ECA-B9D7-F4DFDC1A8312

Q33830084-7686E2BF-1F55-443A-90EA-51459153E021

Q33830084-7B40DB84-04C7-4395-BEE8-3B17A17A7686

Q33830084-8415C43C-C5B9-43A0-8861-626EDF28ED50

Q33830084-A0278847-636A-4210-82D1-E334849DBBC5

P304

Q33830084-76D8F624-E746-4488-ABAC-530DD8F43575

P31

Q33830084-B0F6421F-5810-4BAF-B956-89900CE78624

P356

Q33830084-FB6CB76D-5293-47A4-8AA1-1AD25FF417EB

P433

Q33830084-C4D94081-DF21-4D1E-B651-E34EF5F3AC99

P478

Q33830084-B7BD232E-675D-4102-9070-ED011C51E4E8

P577

Q33830084-9E05BB21-B34F-4AA5-B12B-99D88EFC3D87

P5875

Q33830084-3CFC26B7-FFFD-4899-A102-40E0E83D6017

P698

Q33830084-6179FF25-C510-47A8-B8BE-67D9CF39F06A

P921

Q33830084-07E4ADF2-2DB4-472F-B84A-57322AE23FE2

Q33830084-FD117B25-A4E7-4C00-AAC6-8D784658338E

P932

Q33830084-15FA7B10-9BE8-444A-861B-FBB45B30179F

P356

STI.2008.032300

P1433

Sexually Transmitted Infections

P1476

Pregnancy outcome in women inf ...... before versus after conception

@en

P2093

C B Hofer

http://www.w3.org/2001/XMLSchema#string

E S Machado

http://www.w3.org/2001/XMLSchema#string

I F A Farias

http://www.w3.org/2001/XMLSchema#string

J S Lambert

http://www.w3.org/2001/XMLSchema#string

L A Evangelista

http://www.w3.org/2001/XMLSchema#string

M F L Garcia

http://www.w3.org/2001/XMLSchema#string

R C Neves

http://www.w3.org/2001/XMLSchema#string

R H Oliveira

http://www.w3.org/2001/XMLSchema#string

R T C Mercadante

http://www.w3.org/2001/XMLSchema#string

S A Nogueira

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy.

Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA.

Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis.

Weight loss during pregnancy is associated with adverse pregnancy outcomes among HIV-1 infected women.

Pregnancy outcomes in women with chronic hypertension: a population-based study.

Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women.

Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland.

P304

82-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/STI.2008.032300

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23454244

http://www.w3.org/2001/XMLSchema#string

P698

18987014

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

2864649

http://www.w3.org/2001/XMLSchema#string